In 2022, the Inflation Reduction Act authorized and required Health and Human Services for the first time to negotiate the maximum price drug manufacturers can charge Medicare plans for 10 popular ...
Medicare enrollees could save roughly half of what they usually pay for certain drugs next year, according to a study from the AARP. The study, published Thursday, found that the out-of-pocket cost of ...
Medicare's cap on out-of-pocket costs helps cancer patients and others taking expensive drugs. With less financial burden, ...
A provision of the summer’s One Big Beautiful Bill Act bumping a slew of orphan drugs from Medicare price negotiation is estimated to cost the program $8.8 billion over the course of a decade, ...
As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely mentioned Medicare’s drug price negotiation program — even though the government is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback